Advisory: Research alert on Kailera Therapeutics withdrawn
14/05/2026 06:25
May 14 (Reuters) - An alert on TD Cowen starting coverage on Kailera Therapeutics Inc KLRA.O is dated and has been withdrawn. There will be no substitute. STORY_NUMBER:FWN41R08Z STORY_DATE:14/05/2026 STORY_TIME:[05:08:26] ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Kailera Therapeutics
See all newsKardigan surges in Nasdaq debut after upsized $400 million IPO (updated)
Brief: Kailera Therapeutics Says Phase 2 Ribupatide Oral Shows Up To 12.1% Mean Weight Loss At 26 Weeks
Advisory: Research alert on Kailera Therapeutics withdrawn
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut (updated)
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut